-
Maker of Argentina's first Oscar-winning film, Luis Puenzo, dies at 80:
-
Rape retrial hears Weinstein 'preyed' on aspiring US actress
-
Arrests, hangings, blackout: Iran cranks up wartime repression
-
Seixas relishes 'steep' challenge at Fleche Wallonne
-
US Fed chair nominee says will not be controlled by Trump
-
Singapore's Tang gets second term at UN's patent agency
-
Taiwan leader postpones Eswatini trip after overflight permits revoked
-
Lula warns will respond after US expels police attache
-
Trailblazer Karren Brady steps down from West Ham role
-
US Fed chair nominee says he will not be controlled by Trump
-
Stocks slip, oil climbs as US-Iran truce expiry looms
-
In Portugal, Lula urges return to multilateralism
-
Sinner wants to use Madrid to boost career Grand Slam chances
-
Renewables key to buffer fossil fuel energy shock: COP31 co-hosts
-
Chery wants to make small electric car in Europe
-
Donovan steps down as Bulls coach
-
US official says gas prices have peaked despite Iran war
-
Pope calls for 'law and justice' on Equatorial Guinea visit
-
Trump's Fed chair pick vows to safeguard independence at confirmation hearing
-
Mideast war lights fire under energy transition plans
-
Trump says Iran violated truce as doubt surrounds peace talks
-
Djibouti president re-election confirmed with 97% of vote
-
Barcelona need leaders to fulfil Flick's Champions League dream
-
Guardiola hints that Rodri will make swift Man City return
-
'We weren't soft, we were skilled': Nowitzki on NBA's European revolution
-
PSG and Luis Enrique sweat on Vitinha ahead of Champions League semis
-
Counting a billion people: Inside India's mega census drive
-
UK tackles electricity price link to world gas amid Mideast war
-
In south Lebanon's Nabatieh, residents fear a return to war
-
Bangladesh fuel crunch forces hours-long wait at the pump
-
Fondness for Francis undimmed one year after pope's death
-
Oil and stocks steady as US-Iran truce expiry looms
-
Downing Street exerted pressure to OK Mandelson: sacked UK official
-
Pope visits Equatorial Guinea on last stop of Africa tour
-
German investor morale lowest in over 3 years on Iran war fallout
-
FedEx faces French 'genocide' complaint over Israel cargoes
-
No Iran delegation sent to US talks yet as truce expiry nears
-
Rover discovers more building blocks of life on Mars
-
Russia, North Korea connect road bridge ahead of summer opening
-
'Strangled': Pakistan faces economic imperative in Iran war peace push
-
Michael Jackson fans pack Hollywood for biopic premiere
-
Turkey arrests 110 coal miners on hunger strike
-
Associated British Foods to spin off Primark clothes brand
-
Pope visits Eq. Guinea on last stop of Africa tour
-
Hello Kitty's parent company to make own video games
-
Di Matteo says 'vital' for faltering Chelsea to add experience
-
Ex-Spurs star Davids condemns 'lack of quality, lack of management'
-
Turkmenistan, the gas giant increasingly dependent on China
-
Romanian AI music sensation Lolita sparks racism debate
-
Timberwolves battle back to stun Nuggets in NBA playoffs
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
O.Lorenz--BTB